These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2387381)

  • 61. [Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines].
    Kaverina NV; Senova ZP; Lyskovzev VV; Demina LM; Grizenko AN; Skoldinov AP; Femmer K; Poppe H; Stark A; Wunderlich H
    Pharmazie; 1985 Dec; 40(12):830-2. PubMed ID: 4095141
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Summarized presentation of studies on the toxicology of 3-carbethoxyamino-5-dimethylamino-acetyl-10,11- dihydrobenz[b,f]azepine hydrochloride (Bonnecor, GS 015, AWD 19-166)].
    Nürnberger H; Stade K
    Pharmazie; 1985 Dec; 40(12):871-3. PubMed ID: 3841608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Antiarrhythmic effect of Oenanthe javanica (Bl.) DC. injection].
    Ji G; Yao X; Zang Z; Huang Z
    Zhongguo Zhong Yao Za Zhi; 1990 Jul; 15(7):429-31, 448. PubMed ID: 2261077
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effects of bonnecor on transmembrane potentials of cardiomyocytes of the ventricular contractile myocardium of the intact heart and ventricular fibrillation].
    Kobrin VI; Vostrikov VA
    Kardiologiia; 1992 Jun; 32(6):61-3. PubMed ID: 1405299
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor based on the data from an acute drug test].
    Smerdina IS; Fomichev VI; Nesvetov VN; Gorshkov VA; Preobrazhenskiĭ DV
    Kardiologiia; 1993; 33(7):11-4, 3. PubMed ID: 8309173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiarrhythmic properties of Craviten (M-71) in cats and rabbits.
    Chodera A; Banaszkiewicz W; Glinka B
    Pol J Pharmacol Pharm; 1980; 32(6):833-40. PubMed ID: 7243680
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Possibilities for increasing the elimination rate of Bonnecor].
    Fleck C; Schilder L; Schulze U; Pfister M; Stein G; Landmann H; Schwachula G; Bräunlich H
    Z Gesamte Inn Med; 1990 Oct; 45(20):604-9. PubMed ID: 2129177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Use of bonnecor in the treatment of ventricular arrhythmia].
    Fomichev VI; Smerdina IS; Preobrazhenskiĭ DV; Gorshkov VA
    Klin Med (Mosk); 1995; 73(4):44-6. PubMed ID: 7474818
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on a new antiarrhythmic drug changrolin-4-(3',5'-bis [(N-pyrrolidinyl) methyl]-4'-hydroxyanilino)-quinazoline.
    Li LQ; Qu ZX; Wang ZM; Zeng YL; Ding GS; Hu GJ; Yang XY
    Sci Sin; 1979 Oct; 22(10):1220-8. PubMed ID: 515728
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The antiarrhythmic action of the synthetic acetylcholine analog EDIHYP in calcium chloride- and strophanthin-induced heart rhythm disorders].
    Abdikaliev NA; Kalvin'sh IIa; Meerson FZ
    Farmakol Toksikol; 1991; 54(6):25-8. PubMed ID: 1804687
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 74. [Antiarrhythmic properties of the anticonvulsant drug benzonal].
    Saratikov AS; Fateeva SN; Forshkova VK
    Farmakol Toksikol; 1987; 50(6):42-4. PubMed ID: 3436422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dibenzepin as an antifibrillatory agent for spontaneously terminating electrically induced ventricular fibrillation.
    Manoach M; Kauli N; Netz H; Beker B; Assael M
    Isr J Med Sci; 1979 May; 15(5):443-7. PubMed ID: 36362
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacological studies on droxicainide, a new antiarrhythmic agent.
    Aberg G; af Ekenstam B; Smith E
    Arzneimittelforschung; 1983; 33(5):706-10. PubMed ID: 6683549
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pharmacologic studies on the effect of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on the vegetative and central nervous system].
    Rostock A; Hoffmann W; Ploen U; Bartsch R
    Pharmazie; 1985 Dec; 40(12):875-8. PubMed ID: 3841610
    [TBL] [Abstract][Full Text] [Related]  

  • 78. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The experimental anti-arrhythmia properties of the histamine H1 receptor blockader fencarol].
    Iakovlev GM; Skorobogatov VI; Svistov AS; Mironova MI
    Farmakol Toksikol; 1991; 54(5):25-7. PubMed ID: 1686869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
    Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
    Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.